New product penetration
Upcoming SlideShare
Loading in...5
×
 

New product penetration

on

  • 591 views

 

Statistics

Views

Total Views
591
Views on SlideShare
591
Embed Views
0

Actions

Likes
0
Downloads
0
Comments
0

0 Embeds 0

No embeds

Accessibility

Categories

Upload Details

Uploaded via as Microsoft PowerPoint

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

New product penetration New product penetration Presentation Transcript

  • Aarkstore.com | New ProductPenetration: Understanding &Accelerating New Product Uptake http://www.aarkstore.com/
  • Summary"Action is power"This advice is increasingly relevant for pharmaceutical companies whenit comes to shaping the uptake curve of new products in todaysevolving markets.With rapidly changing market factors, new opinion leader groups andthe importance of a products clinical-economic benefits, findingeffective ways to keep pace with these changes is critical. However,many pharma companies are not aware of this, and remain complacentabout taking appropriate action.In New Product Penetration: Understanding & Accelerating New ProductUptake, FirstWord Dossier reviews the differences between complexpharmaceutical adoption curves versus simple textbook bell curves. Itidentifies the latest key drivers and barriers to new product penetration.The report also examines strategic tactics that big pharma are nowusing to improve their uptake curves. http://www.aarkstore.com/
  • Summary Report Overview New Product Penetration: Understanding & Accelerating New Product Uptake summarises the key issues around this important subject. It includes exclusive feedback from in-depth interviews with experienced directors from leading pharmaceutical companies. The report discusses examples of pre and peri-launch tactics companies are using to improve product adoption. It also outlines key questions that you should consider when looking to increase your new product uptake. Key Report Features Views from global marketing directors of leading pharma companies Various tactics to help develop and deliver rapid product uptake The need for combined clinical and economic product benefits The importance of segmenting the market at a clinical, payer and patient level Structural company changes to improve new product penetration The role of non-traditional KOL groups in securing market access Coordination of cross-functional and geographic launch activities Actions that big pharma companies are taking to improve product uptake http://www.aarkstore.com/
  • Summary Key Benefits Understand the multiple factors that affect new pharma product adoption Hear the tactics that industry leaders recommend to improve uptake Recognise unresolved issues that still affect rapid product uptake Prevent and avert internal and external issues that delay market access Review a checklist of key questions to ask when aiming to raise product uptake Identify ways to shape the target market uptake of your new products http://www.aarkstore.com/
  • Table of Contents : Executive summary About this report: Methodology and the case study companies Introduction: Research underpinnings of product uptake > Product uptake: Standard model > Reflecting reality? > Homogeneity of market connections Research findings > What market factors are driving the need for accelerated uptake of new products? > What practices have companies adopted to accelerate the uptake of new products? > Pre-launch activity > Peri-launch activity 1. The importance of strategic marketing fundamentals 2. The role of market access 3. The importance of implementation rigour 4. KOL engagement 5. Evolving sales and marketing models http://www.aarkstore.com/
  •  More Related Reports : FirstImpact: FDA approval of Aubagio Consensus Outlook: Multiple Sclerosis Therapy Trends: Multiple Sclerosis -- KOL Insight and Consensus Outlook Modules Pharmas Future Role in CME Therapy Trends: Rheumatoid Arthritis -- Consensus Outlook Module Therapy Trends: Rheumatoid Arthritis -- KOL Insight and Consensus Outlook Modules Therapy Trends: Rheumatoid Arthritis -- KOL Insight Module Pharma Reputations: Managing Perceptions Pharma sales force shape, size and structure — where next? http://www.aarkstore.com/
  • For More details about above & other Reports plz contact :http://www.aarkstore.com/reports/New-Product-Penetration-Understanding-Accelerating-New-Product-Uptake-213044.html.Contact : PranaliAarkstore.comMob.No.918149852585Email: enquiry@aarkstore.comYou can also request for sample page of above mentionreports on sample@aarkstore.com http://www.aarkstore.com/